TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
MGX

Metagenomi, Inc.

Healthcare · Biotechnology

1.10$ -2.7% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Metagenomi, Inc. (MGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -89 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow MGX
Line item 2021 2022 2023 2024 2025
24 30 -91 -109 -89
0.4 1.7 4.2 5.4 5.3
0.4 2.0 6.9 16 12
46 69 -26 -60 -22
2.9 14 9.8 3.1 0.6
-74 -122 46 -88 104
30 0.0
40 240 1.0 84 -0.4
-10 147 -45 -113 14
21 16 -101 -112 -89

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?